OIG OPINION

Is Your Billing Company Putting You At Compliance Risk?

By Sean McSweeney  bio Does your orthopedic billing company charge a percentage of collections for their coding and billing? They might break out separate charges for statements or other … [Read more...]

COMPLIANCE PLANS

OIG Monthly Work Plan Review: July 2019

This month there is only one new Work Plan item. Although it doesn't directly impact laboratory operations, it may be of interest to some labs. Quality of Maternal Healthcare in Indian Health Service … [Read more...]

COMPLIANCE PLANS

OIG Monthly Work Plan Review: June 2019

This month, there were seven new Work Plan items. Two of these, detailed below, may have implications for some labs. Opioid Use in Medicare Part D in 2018 Issue: The opioid crisis remains a public … [Read more...]

GENETIC TESTING

OIG Issues Genetic Testing Fraud Alert

On June 3, the OIG issued a fraud alert warning of a genetic testing fraud scheme. According to the OIG, scammers are using telemarketing calls, booths at health fairs and public events and … [Read more...]

COMPLIANCE

New OIG Report Confirms that Labs Are Still on the Enforcement Radar

After a recent dip, OIG enforcement activity has seemingly rebounded, at least in terms of total recoveries. That's the basic punchline from the newly published OIG Semiannual Report to Congress … [Read more...]

COMPLIANCE

New OIG Report Confirms that Labs Are Still on the Enforcement Radar

After a recent dip, OIG enforcement activity has seemingly rebounded, at least in terms of total recoveries. That's the basic punchline from the newly published OIG Semiannual Report to Congress … [Read more...]

COMPLIANCE PLANS

OIG Monthly Work Plan Review: May 2019

Of the three new items in this month's OIG Work Plan items, one may have implications for some labs. Access to Medication-Assisted Treatment at Health Centers Issue: Medication-assisted … [Read more...]

ENFORCEMENT

Case of the Month: Milwaukee Clinic the Latest MD-Owned Lab Busted for Urine Drug Test Abuses

Fraudulent utilization and billing of urine drug screening has become a priority for federal enforcers since the $256 million Millennium settlement of 2016. Subsequent cases have targeted abuses … [Read more...]

COMPLIANCE PLANS

OIG Monthly Work Plan Review: April 2019

Among the 10 new Work Plan items this month, three may have potential ramifications for at least some labs. Medicaid Managed Care Organization Denials Issue: The State Medicaid agency and the … [Read more...]

SELF-DISCLOSURE

Compliance Perspectives: How the New OIG Fraud Risk Indicator System Heightens the Imperative of Self-Disclosure

As hard as you try to keep your lab 100% compliant with healthcare fraud and abuse laws, you may discover that an inadvertent violation has occurred. At that point, the compliance imperative switches … [Read more...]


(-00000g2)